Insider Transactions in Q2 2023 at Seres Therapeutics, Inc. (MCRB)
Insider Transaction List (Q2 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Apr 28
2023
|
David S. Ege |
SELL
Open market or private sale
|
Direct |
7,038
-10.55%
|
$35,190
$5.19 P/Share
|
|
Apr 27
2023
|
David S. Ege |
BUY
Grant, award, or other acquisition
|
Direct |
20,000
+23.06%
|
-
|
|
Apr 27
2023
|
David Arkowitz Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
42,500
+20.32%
|
-
|